Latest filing published 14 Aug 2026 for C4 Therapeutics, Inc., €15k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Mark Mossler on record concern C4 Therapeutics, Inc. In total, 3 filings cover trades dated from 12 August 2026 to 14 August 2026.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 14 August 2026 with a transaction (€15k) in C4 Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations